Sienna Biopharmaceuticals Total Liabilities

Sienna Biopharmaceuticals (SNNAQ) currently reports a total liabilities of $20M as of September 2019. That compares with $80M in the prior-year period — down 74.4% year over year. Use the charts on this page to explore Sienna Biopharmaceuticals's total liabilities history and peer comparisons.

Sienna Biopharmaceuticals's total liabilities decreased from $80M to $20M — a 74.4% year-over-year decrease (period ending September 2019). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Sienna Biopharmaceuticals reported $20M in total liabilities as of September 2019. That compares with $80M in the prior-year period — down 74.4% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total liabilities of $20M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Sienna Biopharmaceuticals, and consider following SNNAQ for alerts when major investors trade the stock.

Sienna Biopharmaceuticals is classified in the Healthcare sector. On total liabilities, it currently shows $20M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing SNNAQ with unrelated industries.